Novartis Pharma: Funding, Team & Investors | Startup Intros

Loading organizations...

Novartis Pharma: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jul 24, 2024	Dren Bio	$25.0M Other Equity	Novartis Pharma	—
Oct 1, 2022	Alto Neuroscience	$35.0M Series B	Jeff Chen, Ph.D., Christopher Cox	7BC Venture Capital, Champion Hill Labs, Crosscut Ventures, Scott Hartley, Future Africa, LombardStreet Ventures, Presight Capital, What If Ventures, Charles Delingpole, Christian Faes, Apeiron Investment Group, Gaingels, Korify Capital, Robert Baloh, Sobrato Capital, Valor Equity Partners, Vine Ventures, Windham Venture Partners
Nov 10, 2021	Mekonos	$25.0M Series A	Lambert Potin, Elementum Ventures, Fiscus Ventures, Novartis Pharma, PEAK6 Strategic Capital, Reimagined Ventures, Sands Capital, Section 32, Nicolas Sauvage	—
Sep 22, 2021	Credence MedSystems	$39.9M Other Equity	—	Molex Ventures
Jun 1, 2021	NuvoAir	$12.0M Series A	Albion VC	Amino Collective, Ananda Impact Ventures, LocalGlobe, Webtalk Ltd, Industrifonden, KAYA, Spiltan
Oct 1, 2020	Vineti	$33.0M Series C	Heidi Hunter	Asset Management Ventures, B Capital Group, BoxGroup, Canaan Partners, Harrison Metal, HealthQuest Capital, Khosla Ventures, Section 32, SV Health Investors, Valar Ventures, Aaron Levie, Marc Benioff, Nina Kjellson, Eli Casdin, LifeForce Capital, McKesson Ventures, Neil Tiwari, Threshold Ventures
Sep 29, 2020	Koneksa Health	$16.0M Series B	—	MBX Capital, Carrie (Hurwitz) Williams, Merck, Rana Lonnen, Robbie Greenglass
Apr 22, 2019	Poseida Therapeutics	$142.0M Series C	Novartis Pharma	Aisling Capital, Boxer Capital, Longitude Capital, Malin Corporation, Pentwater Capital Management, Perceptive Advisors, Vivo Capital